- Home
- CVAC vs BTT Comparison
CVAC vs BTT Comparison
Compare CVAC & BTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CVAC | BTT |
|---|---|---|
| Founded | 2000 | 2012 |
| Country | Germany | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVAC | BTT |
|---|---|---|
| Price | $5.17 | $22.57 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.83 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 151.1K |
| Earning Date | 11-24-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.95% |
| EPS Growth | ★ 94.02 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $83,000,117.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.40 | N/A |
| P/E Ratio | $5.51 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.48 | $18.90 |
| 52 Week High | $5.72 | $21.86 |
Technical Indicators
Market Signals| Indicator | CVAC | BTT |
|---|---|---|
| Relative Strength Index (RSI) | 44.01 | 59.24 |
| Support Level | $5.11 | $22.34 |
| Resistance Level | $5.55 | $22.60 |
| Average True Range (ATR) | 0.12 | 0.16 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 35.00 | 91.30 |
Price Performance
Historical ComparisonAbout CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About BTT BlackRock Municipal 2030 Target Term Trust
Blackrock Municipal 2030 Target Term Trust is a United States-based closed-end management investment company. The investment objective of the company is to provide current income exempt from regular federal income tax and to return $25.00 per common share to holders of common shares. The trust seeks to achieve its investment objectives by investing a majority of its assets in municipal bonds exempt from U.S. federal income taxes.